Table 1 Summary of respondents’ characteristics (n = 126)
From: Risks of nutrigenomics and nutrigenetics? What the scientists say
Respondent characteristic | (%) | Notes |
|---|---|---|
Gender | ||
Male | 52 | |
Female | 48 | |
Age | ||
≤30 | 3 | |
31–40 | 27 | |
41–50 | 29 | |
51–60 | 28 | |
≥61 | 13 | |
Continent of residence | ||
Europe1 | 58 | 1Europe: UK, Netherlands, Spain, Italy, Germany, France, Sweden, Denmark, Finland, Greece, Switzerland, Croatia, Austria, Czech, Republic, Norway, Poland |
North America2 | 31 | 2North America: United States, Canada |
Other3 | 11 | 3Other: Brazil, China, Malaysia, New Zealand, India, Japan, Australia, Israel, Singapore |
Professional status | ||
Professor4 | 73 | 4Indicated full, associate or assistant professor as at least one professional status |
Other5 | 26 | 5Respondents who did not indicate “professor”, and included at least one of the following: MD, postdoctoral student, research director, institute/contract research organization director/president, senior scientist, dietician, researcher, research fellow, retired, dean, PhD student, plastic surgeon, science communication professional, chief operating officer |
Not specified | 1 | |
Affiliation | ||
Private entity (part or full)6 | 12 | 6Private laboratory or organization, private hospital/clinic |
Public entity only7 | 88 | 7University, public hospital/clinic, public research institute, nonprofit organization (e.g., trust, charity, research organization), government science laboratory |
Experience in research (years) | ||
<10 | 17 | |
10–19 | 33 | |
20–29 | 27 | |
≥30 | 23 | |
Diseases targeted by respondents’ research | ||
Metabolic diseases (e.g., diabetes, obesity) | 23 | |
Cancer | 15 | |
HBVD8 | 9 | 8Heart and Blood Vessel Diseases (HBVD) |
Combination of the preceding categories | 9 | |
Other9 | 27 | 9Other diseases or fields of research such as autoimmune diseases, molecular nutrition, fetal development, aging, gut microbial gene and physiology, food safety, systems biology, basic research in various fields, etc. |
Not specified | 17 | |
Respondents’ research conducted in:10 | 10Total >100 as some respondents conduct research in >1 continent | |
Europe | 64 | |
North America | 43 | |
Other11 | 13 | 11Other: Australasia (Australia and New Zealand), South America (Brazil), Asia (China, Malaysia, India, Japan, Singapore, Israel), Africa (Morocco) |
Not specified | 2 | |
Sources of funding for respondents’ research: | ||
Public only12 | 64 | 12Government agencies, universities, not-for-profit organizations (trusts, charities, foundations, etc.), European community, including mentions of “European project” and “International funding” |
Private (part or full)13 | 30 | 13For-profit companies and/or private/public partnerships |
Not specified | 6 | |